Evidence map›Paper›PMID 37049918›Full record

ArticleMolecules (Basel, Switzerland)2023

Preclinical Evaluation of [

Luke Wharton, Scott W McNeil, Helen Merkens, Zheliang Yuan, Michiel Van de Voorde, Gokce Engudar, Aidan Ingham, Helena Koniar, Cristina Rodríguez-Rodríguez, Valery Radchenko and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Quantitative SPECT imaging ofEJNMMI physics · 2024
    Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Luke WhartonLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.ORCID 0000-0002-0636-8741
Scott W McNeilLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.ORCID 0000-0001-8121-8471
Helen MerkensDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Zheliang YuanLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.ORCID 0000-0001-9674-9961
Michiel Van de VoordeNuclear Medicine Applications, Belgium Nuclear Research Center (SCK CEN), Boeretang, 200, 2400 Mol, Belgium.ORCID 0000-0002-1176-9056
Gokce EngudarLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.
Aidan InghamLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.ORCID 0000-0001-6917-0161
Helena KoniarLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.ORCID 0000-0003-0794-9115
Cristina Rodríguez-RodríguezDepartment of Physics and Astronomy, University of British Columbia, 6224 Agronomy Road, Vancouver, BC V6T 1Z1, Canada.ORCID 0000-0002-3313-4422
Valery RadchenkoLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.
Maarten OomsNuclear Medicine Applications, Belgium Nuclear Research Center (SCK CEN), Boeretang, 200, 2400 Mol, Belgium.ORCID 0000-0002-7489-1630
Peter KunzAccelerator Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.
François BénardDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.ORCID 0000-0001-7995-3581
Paul SchafferLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.ORCID 0000-0002-6392-8792
Hua YangLife Sciences Division, TRIUMF, 4004 Wesbrook Mall, Vancouver, BC V6T 2A3, Canada.ORCID 0000-0003-1833-9515
TRIUMF · CABelgian Nuclear Research Centre · BEUniversity of British Columbia · CATerry Fox Research Institute · CA

Funding

Natural Sciences and Engineering Research Council RGPIN-2018-04997Natural Sciences and Engineering Research Council RGPIN-2022-03887Neuroendocrine Tumor Research Foundation 865675
6 · The paper itself

Abstract

Terbium radioisotopes (

Indexed as

Neuroendocrine TumorsAnimalsHumansMaleMicePrecision MedicineRadioisotopesRadiopharmaceuticalsTissue DistributionTomography, Emission-Computed, Single-PhotonRadioisotopesRadiopharmaceuticalsNETsPRRTSPECT imagingTerbium-155Terbium-161theranostics

Identifiers

PMID37049918
PMCPMC10095901
OpenAlexW4362585199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.